Trans-species polymorphism in humans and the great apes is generally maintained by balancing selection that modulates the host immune response

Human Genomics

Volumn 9, Issue 1, 2015, Pages

  Azevedo, Luisa ^a,b   Serrano, Catarina ^a,b   Amorim, Antonio ^a,b   Cooper, David N ^c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCING SELECTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; NONHUMAN; PRIMATE; SPECIES; ANIMAL; BLOOD GROUP ABO SYSTEM; GENETIC POLYMORPHISM; GENETIC SELECTION; GENETICS; HOMINID; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR EVOLUTION;

AUTOANTIGEN; BLOOD GROUP ABO SYSTEM; CARRIER PROTEIN; COLLAGEN TYPE 17; NONFIBRILLAR COLLAGEN; RNA BINDING PROTEIN; TRIM5 PROTEIN, HUMAN; ZC3HAV1 PROTEIN, HUMAN;

ABO BLOOD-GROUP SYSTEM; ANIMALS; AUTOANTIGENS; CARRIER PROTEINS; EVOLUTION, MOLECULAR; HOMINIDAE; HUMANS; IMMUNITY, INNATE; MAJOR HISTOCOMPATIBILITY COMPLEX; NON-FIBRILLAR COLLAGENS; POLYMORPHISM, GENETIC; RNA-BINDING PROTEINS; SELECTION, GENETIC;

EID: 84979851795     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/s40246-015-0043-1     Document Type: Review

References (69)

1. Klein J. Origin of major histocompatibility complex polymorphism: the trans-species hypothesis. Hum Immunol. 1987;19(3):155-62.
2. Leffler EM, Gao Z, Pfeifer S, Ségurel L, Auton A, Venn O, et al. Multiple instances of ancient balancing selection shared between humans and chimpanzees. Science. 2013;339(6127):1578-82.
3. Cagliani R, Fumagalli M, Riva S, Pozzoli U, Comi GP, Menozzi G, et al. The signature of long-standing balancing selection at the human defensin β-1 promoter. Genome Biol. 2008;9(9):R143-R.
4. Gyllensten UB, Erlich HA. Ancient roots for polymorphism at the HLA-DQ alpha locus in primates. Proc Natl Acad Sci U S A. 1989;86(24):9986-90.
5. Asthana S, Schmidt S, Sunyaev S. A limited role for balancing selection. Trends Genet. 2005;21(1):30-2.
6. Mayer WE, Jonker M, Klein D, Ivanyi P, van Seventer G, Klein J. Nucleotide sequences of chimpanzee MHC class I alleles: evidence for trans-species mode of evolution. EMBO J. 1988;7(9):2765-74.
7. Spurgin LG, Richardson DS. How pathogens drive genetic diversity: MHC, mechanisms and misunderstandings. Proc R Soc B. 2010;277(1684):979-88.
8. Sommer S. The importance of immune gene variability (MHC) in evolutionary ecology and conservation. Front Zool. 2005;2(1):16.
9. Langergraber KE, Prüfer K, Rowney C, Boesch C, Crockford C, Fawcett K, et al. Generation times in wild chimpanzees and gorillas suggest earlier divergence times in great ape and human evolution. Proc Natl Acad Sci U S A. 2012;109(39):15716-21.
10. Scally A, Dutheil JY, Hillier LW, Jordan GE, Goodhead I, Herrero J, et al. Insights into hominid evolution from the gorilla genome sequence. Nature. 2012;483(7388):169-75.
11. Wroblewski EE, Norman PJ, Guethlein LA, Rudicell RS, Ramirez MA, Li Y, et al. Signature patterns of MHC diversity in three Gombe communities of wild chimpanzees reflect fitness in reproduction and immune defense against SIVcpz. PLoS Biol. 2015;13(5), e1002144.
12. Otting N, de Groot N, Doxiadis G, Bontrop R. Extensive Mhc-DQB variation in humans and non-human primate species. Immunogenetics. 2002;54(4):230-9.
13. Yao Y-F, Dai Q-X, Li J, Ni Q-Y, Zhang M-W, Xu H-L. Genetic diversity and differentiation of the rhesus macaque (Macaca mulatta) population in western Sichuan, China, based on the second exon of the major histocompatibility complex class II DQB (MhcMamu-DQB1) alleles. BMC Evol Biol. 2014;14(1):130.
14. Go Y, Satta Y, Kawamoto Y, Rakotoarisoa G, Randrianjafy A, Koyama N, et al. Mhc-DRB genes evolution in lemurs. Immunogenetics. 2002;54(6):403-17.
15. Figueroa F, Gunther E, Klein J. MHC polymorphism pre-dating speciation. Nature. 1988;335(6187):265-7.
16. Kuduk K, Babik W, Bojarska K, Śliwińska EB, Kindberg J, Taberlet P, et al. Evolution of major histocompatibility complex class I and class II genes in the brown bear. BMC Evol Biol. 2012;12:197.
17. Meyer-Lucht Y, Otten C, Püttker T, Sommer S. Selection, diversity and evolutionary patterns of the MHC class II DAB in free-ranging neotropical marsupials. BMC Genet. 2008;9:39.
18. Kamath P, Getz W. Adaptive molecular evolution of the Major Histocompatibility Complex genes, DRA and DQA, in the genus Equus. BMC Evol Biol. 2011;11(1):128.
19. Těšický M, Vinkler M. Trans-species polymorphism in immune genes: general pattern or MHC-restricted phenomenon? J Immunol Res. 2015;2015:838035.
20. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature. 1990;345(6272):229-33.
21. Martinko JM, Vincek V, Klein D, Klein J. Primate ABO glycosyltransferases: evidence for trans-species evolution. Immunogenetics. 1993;37(4):274-8.
22. Yamamoto F, Cid E, Yamamoto M, Saitou N, Bertranpetit J, Blancher A. An integrative evolution theory of histo-blood group ABO and related genes. Sci Rep. 2014;4.
23. Ségurel L, Thompson EE, Flutre T, Lovstad J, Venkat A, Margulis SW, et al. The ABO blood group is a trans-species polymorphism in primates. Proc Natl Acad Sci U S A. 2012;109(45):18493-8.
24. Steiper ME, Young NM. Primate molecular divergence dates. Mol Phylogenet Evol. 2006;41(2):384-94.
25. Boren T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science. 1993;262(5141):1892-5.
26. Anstee DJ. The relationship between blood groups and disease. Blood. 2010;115(23):4635-43.
27. Harris JB, Khan AI, LaRocque RC, Dorer DJ, Chowdhury F, Faruque ASG, et al. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun. 2005;73(11):7422-7.
28. Duell EJ, Bonet C, Muñoz X, Lujan-Barroso L, Weiderpass E, Boutron-Ruault M-C, et al. Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population. Int J Cancer. 2015;136(4):880-93.
29. Rizzato C, Kato I, Plummer M, Muñoz N, Stein A., Jan van Doorn L, et al. Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status. Int J Cancer. 2013;133(2):315-22.
30. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41(9):986-90.
31. Risch HA. Pancreatic cancer: Helicobacter pylori colonization, N-Nitrosamine exposures, and ABO blood group. Mol Carcinogen. 2012;51(1):109-18.
32. Gao G, Guo X, Goff SP. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science. 2002;297(5587):1703-6.
33. Mao R, Nie H, Cai D, Zhang J, Liu H, Yan R, et al. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog. 2013;9(7), e1003494.
34. Kerns JA, Emerman M, Malik HS. Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. PLoS Genet. 2008;4(1), e21.
35. Guo X, Carroll J-WN, MacDonald MR, Goff SP, Gao G. The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs. J Virol. 2004;78(23):12781-7.
36. Todorova T, Bock FJ, Chang P. Poly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer. Trends Mol Med. 2015;21(6):373-84.
37. Cagliani R, Guerini FR, Fumagalli M, Riva S, Agliardi C, Galimberti D, et al. A trans-specific polymorphism in ZC3HAV1 is maintained by long-standing balancing selection and may confer susceptibility to multiple sclerosis. Mol Biol Evol. 2012;29(6):1599-613.
38. Bieniasz PD. Intrinsic immunity: a front-line defense against viral attack. Nat Immunol. 2004;5(11):1109-15.
39. Kaiser SM, Malik HS, Emerman M. Restriction of an extinct retrovirus by the human TRIM5α antiviral protein. Science. 2007;316(5832):1756-8.
40. Goldschmidt V, Ciuffi A, Ortiz M, Brawand D, Muñoz M, Kaessmann H, et al. Antiretroviral activity of ancestral TRIM5α. J Virol. 2008;82(5):2089-96.
41. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5[alpha] restricts HIV-1 infection in Old World monkeys. Nature. 2004;427(6977):848-53.
42. Schaller T, Hué S, Towers GJ. An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins. J Virol. 2007;81(21):11713-21.
43. Fletcher AJ, Hué S, Schaller T, Pillay D, Towers GJ. Hare TRIM5α restricts divergent retroviruses and exhibits significant sequence variation from closely related lagomorpha TRIM5 genes. J Virol. 2010;84(23):12463-8.
44. Ylinen LMJ, Keckesova Z, Webb BLJ, Gifford RJM, Smith TPL, Towers GJ. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals. J Virol. 2006;80(15):7332-8.
45. Jáuregui P, Crespo H, Glaria I, Luján L, Contreras A, Rosati S, et al. Ovine TRIM5α can restrict Visna/Maedi virus. J Virol. 2012.
46. Sawyer SL, Wu LI, Emerman M, Malik HS. Positive selection of primate TRIM5α identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A. 2005;102(8):2832-7.
47. Newman RM, Hall L, Connole M, Chen GL, Sato S, Yuste E, et al. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha. Proc Natl Acad Sci U S A. 2006;103(50):19134-9.
48. Cagliani R, Fumagalli M, Biasin M, Piacentini L, Riva S, Pozzoli U, et al. Longterm balancing selection maintains trans-specific polymorphisms in the human TRIM5 gene. Hum Genet. 2010;128(6):577-88.
49. Loisel DA, Rockman MV, Wray GA, Altmann J, Alberts SC. Ancient polymorphism and functional variation in the primate MHC-DQA1 5′ cis-regulatory region. Proc Natl Acad Sci U S A. 2006;103(44):16331-6.
50. Arbiza L, Gronau I, Aksoy BA, Hubisz MJ, Gulko B, Keinan A, et al. Genomewide inference of natural selection on human transcription factor binding sites. Nat Genet. 2013;45(7):723-9.
51. Schaschl H, Huber S, Schaefer K, Windhager S, Wallner B, Fieder M. Signatures of positive selection in the cis-regulatory sequences of the human oxytocin receptor (OXTR) and arginine vasopressin receptor 1a (AVPR1A) genes. BMC Evol Biol. 2015;15:85.
52. Sellis D, Callahan BJ, Petrov DA, Messer PW. Heterozygote advantage as a natural consequence of adaptation in diploids. Proc Natl Acad Sci U S A. 2011;108(51):20666-71.
53. Siegert S, Wolf A, Cooper DN, Krawczak M, Nothnagel M. Mutations causing complex disease may under certain circumstances be protective in an epidemiological sense. PLoS One. 2015;10(7), e0132150.
54. Teixeira JC, de Filippo C, Weihmann A, Meneu JR, Racimo F, Dannemann M, et al. Long-term balancing selection in LAD1 maintains a missense trans-species polymorphism in humans, chimpanzees, and bonobos. Mol Biol Evol. 2015;32(5):1186-96.
55. Marinkovich MP, Taylor TB, Keene DR, Burgeson RE, Zone JJ. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol. 1996;106(4):734-8.
56. Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin Exp Immunol. 2009;155(1):1-15.
57. Ahkami R, Thomas I. Linear IgA bullous dermatosis associated with vancomycin and disseminated varicella-zoster infection. Cutis. 2001;67(5):423-6.
58. Hughes AL, Nei M. Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature. 1988;335(6186):167-70.
59. Takahata N, Nei M. Allelic genealogy under overdominant and frequencydependent selection and polymorphism of major histocompatibility complex loci. Genetics. 1990;124(4):967-78.
60. Penn DJ, Damjanovich K, Potts WK. MHC heterozygosity confers a selective advantage against multiple-strain infections. Proc Natl Acad Sci U S A. 2002;99(17):11260-4.
61. Borghans JM, Beltman J, De Boer R. MHC polymorphism under host-pathogen coevolution. Immunogenetics. 2004;55(11):732-9.
62. Ségurel L, Gao Z, Przeworski M. Ancestry runs deeper than blood: the evolutionary history of ABO points to cryptic variation of functional importance. Bioessays. 2013;35(10):862-7.
63. Villanea FA, Safi KN, Busch JW. A general model of negative frequency dependent selection explains global patterns of human ABO polymorphism. PLoS One. 2015;10(5), e0125003.
64. Fumagalli M, Sironi M, Pozzoli U, Ferrer-Admettla A, Pattini L, Nielsen R. Signatures of environmental genetic adaptation pinpoint pathogens as the main selective pressure through human evolution. PLoS Genet. 2011;7(11), e1002355.
65. Sironi M, Cagliani R, Forni D, Clerici M. Evolutionary insights into hostpathogen interactions from mammalian sequence data. Nat Rev Genet. 2015;16(4):224-36.
66. Siddle KJ, Quintana-Murci L. The Red Queen's long race: human adaptation to pathogen pressure. Curr Opin Genet Dev. 2014;29:31-8.
67. Andrés AM, Hubisz MJ, Indap A, Torgerson DG, Degenhardt JD, Boyko AR, et al. Targets of balancing selection in the human genome. Mol Biol Evol. 2009;26(12):2755-64.
68. Key FM, Teixeira JC, de Filippo C, Andrés AM. Advantageous diversity maintained by balancing selection in humans. Curr Opin Genet Dev. 2014;29:45-51.
69. Database of Single Nucleotide Polymorphisms (dbSNP). Available from: [http://www.ncbi.nlm.nih.gov/SNP].